Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
June 23, 2022
Magnetic Insight Raises $17M Series B to Expand Magnetic Particle Imaging and Monitoring Technology into Clinical Applications
June 16, 2022
GlycoEra AG Announces Appointment of Tanmoy Ganguly, Ph.D., as Chief Scientific Officer
June 13, 2022
Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&D Lab Facilities
June 13, 2022
Homology Medicines Announces FDA Lifted Clinical Hold on pheNIX Gene Therapy Trial for PKU
June 10, 2022
Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA
June 10, 2022
Inipharm Appoints Chuhan Chung, M.D, as Chief Medical Officer to Advance HSD17B13 Program into the Clinic
June 6, 2022
Artiva Biotherapeutics Appoints Dr. Thorsten Graef as Chief Medical Officer
June 1, 2022
CinCor Pharma Doses First Patient in Phase 2 FigHTN-CKD Trial Evaluating the Selective Aldosterone Synthase Inhibitor Baxdrostat (CIN-107) in Patients with Uncontrolled Hypertension and Chronic Kidney Disease
June 1, 2022
Nouscom to Present Full Phase 1 Data of NOUS-209, an “Off-The-Shelf” Neoantigen Cancer Immunotherapy for the Treatment of DMMR/MSI-H Solid Tumors, at ASCO 2022
May 23, 2022
Nouscom Announces Promotion of Richard Davis to Chief Operating Officer
« Previous Page
1
…
25
26
27
28
29
…
118
Next Page »